Psoriatic Arthritis Treatment Global Market Report 2025

Description

Psoriatic arthritis treatment aims to mitigate or halt the progression of a chronic inflammatory condition affecting joints and the areas where tendons and ligaments attach to bones (entheses). This treatment regimen concentrates on managing skin involvement, alleviating joint pain, and addressing associated disability.

The primary classes of drugs used in psoriatic arthritis treatment encompass nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, and other medications. Biologic medicines, a subset of treatment options, are substances derived from or containing components of living organisms. These medications can be administered through various routes, including oral, parenteral (injection or infusion), and topical applications. They are distributed through diverse channels such as hospital pharmacies, retail pharmacies, and online pharmacies to cater to the needs of patients undergoing psoriatic arthritis treatment.

The psoriatic arthritis treatment market research report is one of a series of new reports from The Business Research Company that provides psoriatic arthritis treatment market statistics, including global market size, regional shares, competitors with a psoriatic arthritis treatment market share, detailed psoriatic arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the psoriatic arthritis treatment industry. This psoriatic arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2024 to $12 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increased diagnosis, rising prevalence of psoriatic arthritis, increasing awareness of psoriatic arthritis and its treatments, expanding range of approved psoriatic arthritis treatments, government support for research and development, increased investment from pharmaceutical companies.

The psoriatic arthritis treatment market size is expected to see strong growth in the next few years. It will grow to $17.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to personalized medicine, emerging biologics and small molecules, expanding treatment options, global aging population. Major trends in the forecast period include advancements in biologics, oral small molecules, targeting specific pathways, telemedicine and remote monitoring, patient-centered care, and real-world evidence.

The growing prevalence of psoriasis and psoriatic arthritis has significantly contributed to the expansion of the psoriatic arthritis treatment market. Psoriasis (PSO) and psoriatic arthritis (PsA) are inflammatory conditions that can severely affect health and quality of life. Approximately 30% of individuals with psoriasis also experience psoriatic arthritis. For example, in January 2024, reports from the National Library of Medicine, a US government agency, indicated that the annual incidence of psoriatic arthritis among patients with psoriasis ranges from 1.9% to 2.7% per 100 patients. Over time, the risk of developing PsA increases notably, with incidence rates of 1.7% at five years, 3.1% at ten years, and reaching as high as 20.5% at thirty years after a psoriasis diagnosis. Therefore, the rising incidence of psoriasis and psoriatic arthritis is a key driver of market growth.

The surge in healthcare spending has propelled the growth of the psoriatic arthritis treatment market. Increased healthcare expenditure supports various diagnostic procedures, including medical appointments, laboratory tests, and imaging studies essential for confirming diagnoses like psoriatic arthritis. For instance, in the UK, healthcare spending reached around $347.74 billion in 2022, demonstrating a 0.7% nominal increase from the previous year. This increased investment in healthcare resources contributes to the growth of treatments for conditions like psoriatic arthritis.

Leading companies in the psoriatic arthritis treatment market are increasingly concentrating on developing advanced products, such as targeted biologic therapies, to provide more effective and personalized treatment options. These therapies aim to address the underlying inflammatory processes, improve patient outcomes, and enhance the overall quality of life for individuals living with this chronic condition. Targeted biologic therapy involves using specially designed drugs or substances that interfere with specific molecules involved in the growth and spread of disease, aiming to minimize damage to normal cells while maximizing therapeutic efficacy. For example, in January 2022, AbbVie, a US-based biopharmaceutical company engaged in discovering and developing medicines, announced that the U.S. Food and Drug Administration (FDA) had approved SKYRIZI (risankizumab-rzaa). SKYRIZI is an interleukin-23 inhibitor specifically indicated for the treatment of active psoriatic arthritis, targeting inflammation at its source by blocking the p19 subunit of IL-23. Clinical studies have shown significant improvements in joint symptoms and overall disease activity, with many patients achieving clinical remission and enhanced quality of life. Administered through subcutaneous injection, this therapy provides a convenient option for patients, allowing for flexible dosing schedules tailored to their individual needs.

Major pharmaceutical companies have also been instrumental in market growth by introducing new drugs like Cosentyx. This drug, developed by Novartis, is an interleukin-17A antagonist used to treat various autoimmune diseases, including psoriatic arthritis. In October 2023, its approval by the FDA marked a significant milestone, offering relief for symptoms like joint pain and skin problems associated with psoriatic arthritis.

In February 2023, Takeda Pharmaceutical Company, a Japan-based pharmaceutical company acquired Nimbus Therapeutics for an undisclosed amount. The acquisition is anticipated to improve Takeda Pharmaceutical's position in the market for psoriatic arthritis treatments and broaden its product line. Nimbus Therapeutics is a US-based biotechnology company. It develops drugs for psoriatic arthritis treatment.

Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

North America was the largest region in the psoriatic arthritis treatment market in 2024. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The psoriatic arthritis treatment market includes revenues earned by entities by reducing pain and swelling and controlling inflammation and pain. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Psoriatic Arthritis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psoriatic arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for psoriatic arthritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The psoriatic arthritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biologics; Other Drug Classes
2) By Route Of Administration: Oral; Parenteral; Topical
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs; COX-2 Inhibitors
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs; Targeted Synthetic DMARDs
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors; Other Biologics
4) By Other Drug Classes: Corticosteroids; Topical Treatments; Janus Kinase (JAK) Inhibitors
Companies Mentioned: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32962

1. Executive Summary

2. Psoriatic Arthritis Treatment Market Characteristics

3. Psoriatic Arthritis Treatment Market Trends And Strategies

4. Psoriatic Arthritis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Psoriatic Arthritis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Psoriatic Arthritis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Psoriatic Arthritis Treatment Market Growth Rate Analysis
5.4. Global Psoriatic Arthritis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Psoriatic Arthritis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Psoriatic Arthritis Treatment Total Addressable Market (TAM)

6. Psoriatic Arthritis Treatment Market Segmentation

6.1. Global Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
Disease-Modifying Anti-Rheumatic Drugs (DMARDS)
Biologics
Other Drug Classes
6.2. Global Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Topical
6.3. Global Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Traditional NSAIDs
COX-2 Inhibitors
6.5. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Disease-Modifying Anti-Rheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional DMARDs
Targeted Synthetic DMARDs
6.6. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tumor Necrosis Factor (TNF) Inhibitors
Interleukin Inhibitors
Other Biologics
6.7. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Topical Treatments
Janus Kinase (JAK) Inhibitors

7. Psoriatic Arthritis Treatment Market Regional And Country Analysis

7.1. Global Psoriatic Arthritis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Psoriatic Arthritis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Psoriatic Arthritis Treatment Market

8.1. Asia-Pacific Psoriatic Arthritis Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Psoriatic Arthritis Treatment Market

9.1. China Psoriatic Arthritis Treatment Market Overview
9.2. China Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Psoriatic Arthritis Treatment Market

10.1. India Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Psoriatic Arthritis Treatment Market

11.1. Japan Psoriatic Arthritis Treatment Market Overview
11.2. Japan Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Psoriatic Arthritis Treatment Market

12.1. Australia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Psoriatic Arthritis Treatment Market

13.1. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Psoriatic Arthritis Treatment Market

14.1. South Korea Psoriatic Arthritis Treatment Market Overview
14.2. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Psoriatic Arthritis Treatment Market

15.1. Western Europe Psoriatic Arthritis Treatment Market Overview
15.2. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Psoriatic Arthritis Treatment Market

16.1. UK Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Psoriatic Arthritis Treatment Market

17.1. Germany Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Psoriatic Arthritis Treatment Market

18.1. France Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Psoriatic Arthritis Treatment Market

19.1. Italy Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Psoriatic Arthritis Treatment Market

20.1. Spain Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Psoriatic Arthritis Treatment Market

21.1. Eastern Europe Psoriatic Arthritis Treatment Market Overview
21.2. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Psoriatic Arthritis Treatment Market

22.1. Russia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Psoriatic Arthritis Treatment Market

23.1. North America Psoriatic Arthritis Treatment Market Overview
23.2. North America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Psoriatic Arthritis Treatment Market

24.1. USA Psoriatic Arthritis Treatment Market Overview
24.2. USA Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Psoriatic Arthritis Treatment Market

25.1. Canada Psoriatic Arthritis Treatment Market Overview
25.2. Canada Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Psoriatic Arthritis Treatment Market

26.1. South America Psoriatic Arthritis Treatment Market Overview
26.2. South America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Psoriatic Arthritis Treatment Market

27.1. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Psoriatic Arthritis Treatment Market

28.1. Middle East Psoriatic Arthritis Treatment Market Overview
28.2. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Psoriatic Arthritis Treatment Market

29.1. Africa Psoriatic Arthritis Treatment Market Overview
29.2. Africa Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Psoriatic Arthritis Treatment Market Competitive Landscape And Company Profiles

30.1. Psoriatic Arthritis Treatment Market Competitive Landscape
30.2. Psoriatic Arthritis Treatment Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Amgen Astellas BioPharma K.K. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Celgene Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Psoriatic Arthritis Treatment Market Other Major And Innovative Companies

31.1. Novartis International AG
31.2. Eli Lilly and Company
31.3. Pfizer Inc.
31.4. CB Biosciences Inc.
31.5. Hoffmann-La Roche Ltd.
31.6. Merck & Co. Inc.
31.7. AstraZeneca plc
31.8. Sanofi SA
31.9. Otsuka Pharmaceutical Co. Ltd.
31.10. Sumitomo Dainippon Pharma Co. Ltd.
31.11. Bayer AG
31.12. Abbott Laboratories
31.13. Eisai Inc.
31.14. Janssen Pharmaceuticals Inc.
31.15. Bausch Health Companies Inc.

32. Global Psoriatic Arthritis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Psoriatic Arthritis Treatment Market

34. Recent Developments In The Psoriatic Arthritis Treatment Market

35. Psoriatic Arthritis Treatment Market High Potential Countries, Segments and Strategies

35.1 Psoriatic Arthritis Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Psoriatic Arthritis Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Psoriatic Arthritis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer